SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-140106
Filing Date
2004-08-13
Accepted
2004-08-13 12:14:25
Documents
5
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2004 d10q.htm 10-Q 313080
2 EMPLOYMENT AGREEMENT dex1067.htm EX-10.67 78155
3 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8142
4 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8026
5 SECTION 906 CEO AND CFO CERTIFICATION dex320.htm EX-32.0 4540
  Complete submission text file 0001193125-04-140106.txt   414204
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20945 | Film No.: 04972707
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10